SEC Tracker
Get the app

BeOne Medicines ONC

John Smith, Chief Financial Officer of BeOne Medicines Ltd. (BEIGF), reported the sale of 50,000 shares worth $1.2 million. This insider selling activity signals potential bearish sentiment from company leadership about the near-term prospects of the business.

John Oyler, insider filing for ONC

Form
4
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when BeOne Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  2. Biogen BIIB public float $18.4B, Jun 30, 2025
  3. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  4. INSMED INSM public float $21.1B, Jun 30, 2025
  5. Roivant Sciences ROIV public float $9.8B, Sep 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.